Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG and Interferon Alpha in High Risk Superficial Bladder Cancer
NCT00330707Phase 3Completed
- Sponsor
- National University Hospital
- Start
- Oct 1995
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa in bladder cancer, sponsored by National University Hospital. Started Oct 1995; status: completed.
02
Drugs
interferon alfa
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00330707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330707.